We have used mixed monolayer protected gold clusters (MMPCs) to provide flavoenzyme model systems with a high affinity and ability to modulate cofactor reduction potential.
No takes yet. Share an insight, caveat, or question.
Bayır et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: